| LDO Home | General | Kidney | Liver | Marrow | Experiences | Buddies | Hall of Fame | Calendar | Contact Us |

Author Topic: Implementation of the HIV Organ Policy Equity Act  (Read 2863 times)

0 Members and 1 Guest are viewing this topic.

Offline Clark

  • Administrator
  • Top 10 Poster!
  • *****
  • Posts: 3,019
  • Please give the gift of life!
    • Living Donors Online!
Implementation of the HIV Organ Policy Equity Act
« on: May 08, 2015, 01:26:53 PM »
https://www.federalregister.gov/articles/2015/05/08/2015-11048/organ-procurement-and-transplantation-implementation-of-the-hiv-organ-policy-equity-act



Organ Procurement and Transplantation: Implementation of the HIV Organ Policy Equity Act
A Rule by the Health and Human Services Department on 05/08/2015

Publication Date:Friday, May 08, 2015
Agency:Department of Health and Human Services
Dates:This final rule is effective June 8, 2015.
Effective Date:06/08/2015
Entry Type:RuleAction: Final rule.
Document Citation:80 FR 26464Page:26464 -26467 (4 pages)CFR:42 CFR 121RIN:0906-AB05
Document Number:2015-11048
Shorter URL: https://federalregister.gov/a/2015-11048 

ACTION
Final Rule.
SUMMARY
This final rule amends the regulations implementing the National Organ Transplant Act of 1984, as amended, (NOTA) pursuant to statutory requirements of the HIV Organ Policy Equity Act (HOPE Act), enacted in 2013. In accordance with the mandates of the HOPE Act, this regulation removes the current regulatory provision that requires the Organ Procurement Transplantation Network (OPTN) to adopt and use standards for preventing the acquisition of organs from individuals known to be infected with human immunodeficiency virus (HIV).
In its place, this regulation includes new requirements that organs from individuals infected with HIV may be transplanted only into individuals who are infected with HIV before receiving such organs and who are participating in clinical research approved by an institutional review board, as provided by regulation. The only exception to this requirement of participation in such clinical research is if the Secretary publishes a determination in the future that participation in such clinical research, as a requirement for transplants of organs from individuals infected with HIV, is no longer warranted.
In addition, this regulatory change establishes that OPTN standards must ensure that any HIV-infected transplant recipients are participating in clinical research in accordance with the research criteria to be published by the Secretary. Alternately, if and when the Secretary determines that participation in such clinical research should no longer be a requirement for transplants with organs from donors infected with HIV to individuals infected with HIV, the regulation mandates that the OPTN adopt and use standards of quality, as directed by the Secretary, consistent with the law and in a way that ensures the changes will not reduce the safety of organ transplantation.
...
« Last Edit: May 08, 2015, 01:28:32 PM by Clark »
Unrelated directed kidney donor in 2003, recipient and I both well.
620 time blood and platelet donor since 1976 and still giving!
Elected to the OPTN/UNOS Boards of Directors & Executive, Kidney Transplantation, and Ad Hoc Public Solicitation of Organ Donors Committees, 2005-2011
Proud grandpa!

 

Copyright © International Association of Living Organ Donors, Inc. All Rights Reserved
traditional